Clinical trial reveals positive results for treating children with rare gliomas
Tafinlar and Mekinist led to a 56% overall response rate in children with BM-HGG
Read More
Tag: Novartis
Novartis reveals vital Leqvio data
The therapy involves treating individuals with atherosclerotic cardiovascular disease
Read More
Novartis’ remibrutinib shows promise for patients with CSU
Highly selective inhibitor therapy treats patients with chronic spontaneous urticaria
Read More
Novartis reveals five-year efficacy data for Kesimpta
Patients treated with Kesimpta experienced considerable decreases in relapse rates
Read More
Novartis reveals results from pivotal CML survey
International data questions the assumption that chronic myeloid leukaemia is now a ‘solved’ disease
Read More
EU regulator recommends revoking approval for Novartis’ sickle cell disease drug
The EMA’s human medicines committee concluded that the benefits of Adakveo did not outweigh its risks
Read More
NICE approves funding for Novartis gene therapy
Funding is for onasemnogene abeparvovec and concerns babies with spinal muscular atrophy
Read More
Novartis joins Cancer Research UK on rare cancers study
DETERMINE trial aims to discover if current treatments could benefit patients with other cancer types
Read More
Medicines for Malaria Venture and Novartis move to phase 3 trial
Ganaplacide/lumefantrinein new study as world faces emerging resistance to malaria treatments
Read More
Novartis announces tislelizumab efficacy results from phase 3 trial
Tislelizumab shows favourable safety profile compared to sorafenib among liver cancer patients
Read More
Kaiku Health enters wider partnership with Novartis
Following a successful collaboration, the companies will now partner to focus on precision medicine
Read More
Novartis’ Scemblix approved by the EC for adults with chronic myeloid leukaemia
It is estimated that every year more than 6,300 people will be diagnosed with CML in Europe
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
